远程会诊对系统性红斑狼疮患者后续疾病活动度和复发的影响
本研究纳入2020年2月至2021年2月间就诊的成人SLE患者,比较远程会诊与面对面就诊后下一次随访时的疾病活动度和复发情况。结果显示两种就诊方式在预测复发、SLEDAI-2K评分及泼尼松龙剂量调整上均无显著差异,提示远程会诊在SLE随访中安全性相似。
要点
- 远程会诊与面对面就诊后下一次随访的复发风险无显著差异。
- 两种就诊方式后下一次随访的SLEDAI-2K评分无显著差异。
- 医生根据就诊方式调整泼尼松龙剂量的行为无显著差异。
核心结论
- 远程会诊与面对面就诊后下一次随访的SLE疾病活动度和复发情况相似。
- 两种就诊方式下基于泼尼松龙剂量调整的处方行为无差异。
研究设计与样本
- 研究纳入2020年2月1日至2021年2月1日期间就诊的成人SLE患者,共记录435次就诊。
- 风湿科医生自行选择电话/视频远程会诊或面对面就诊,采用倾向性评分和多变量广义估计方程分析。
主要发现
- 435次就诊中面对面就诊343次(78.9%),远程会诊92次(21.1%)。
- 就诊方式未预测复发(面对面就诊OR=0.42,95%CI 0.04~5.04,P=0.49)。
- 就诊方式未预测下一次随访SLEDAI-2K评分(面对面就诊系数估计=-0.19,95%CI -0.80~0.43,P=0.55)。
- 两种就诊方式间泼尼松龙剂量调整相当(面对面就诊OR=1.34,95%CI 0.77~2.34,P=0.30)。
关键数值与推荐
- 疾病活动度采用SLEDAI-2K评估,复发采用SELENA-SLEDAI Flare Index(SFI)定义。
临床怎么用
- 在SLE患者随访中,远程会诊可作为面对面就诊的替代方式,未增加后续疾病活动或复发风险。
- 医生在远程会诊中调整糖皮质激素剂量的行为与面对面就诊相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Despite the widespread adoption of teleconsultations amid the COVID-19 pandemic, their safety in SLE patients has not been evaluated. Here, we examined subsequent disease activity and flares among SLE patients who received teleconsultation vs in-person consultation. To discern differences in physicians' prescription behaviour during both forms of consultations, we compared corticosteroid dose adjustments. METHODS: We studied adult SLE patients who were seen between 1 February 2020 and 1 February 2021. At each patient-visit, rheumatologists utilized phone/video teleconsultation or physical consultation at their discretion. Disease activity was assessed with SLE Disease Activity Index 2000 (SLEDAI-2K) and flares were defined by the SELENA-SLEDAI Flare Index (SFI). We derived a propensity score for patients who were chosen for physical consultation. Multivariable generalized estimation equations were used to analyse SLEDAI-2k and flare at the next visit, adjusted for the propensity score. RESULTS: A total of 435 visits were recorded, of which 343 (78.9%) were physical visits and 92 (21.1%) were teleconsultations. The modality of consultation did not predict flare [OR for physical consultation (95% CI) 0.42 (0.04, 5.04), P =0.49] or SLEDAI-2k at the next visit [estimate of coefficient for physical consultation (95% CI) -0.19 (-0.80, 0.43), P =0.55]. Adjustments of prednisolone dosages were comparable between the two forms of visits [OR for physical consultation (95% CI) 1.34 (0.77, 2.34), P =0.30]. CONCLUSION: SLE disease activity and flares at the subsequent visit were similar between teleconsultations and physical consultations. Medication prescription behaviour, determined using adjustment in corticosteroid dosages, was not different between the two forms of visits.
引用
- Au Eong JTW, Lateef A, Liang S, et al. Impact of teleconsultation on subsequent disease activity and flares in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2022. PMID: 34554232. doi:10.1093/rheumatology/keab694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。